GPX4 in cell death, autophagy, and disease

Y Xie, R Kang, DJ Klionsky, D Tang - Autophagy, 2023 - Taylor & Francis
ABSTRACT Selenoprotein GPX4 (glutathione peroxidase 4), originally known as PHGPX
(phospholipid hydroperoxide glutathione peroxidase), is the main oxidoreductase in the use …

Natural products in cancer therapy: Past, present and future

M Huang, JJ Lu, J Ding - Natural products and bioprospecting, 2021 - Springer
Natural products, with remarkable chemical diversity, have been extensively investigated for
their anticancer potential for more than a half-century. The collective efforts of the community …

Deubiquitinase-targeting chimeras for targeted protein stabilization

NJ Henning, L Boike, JN Spradlin, CC Ward… - Nature chemical …, 2022 - nature.com
Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These
diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we …

Rational chemical design of molecular glue degraders

ES Toriki, JW Papatzimas, K Nishikawa… - ACS central …, 2023 - ACS Publications
Targeted protein degradation with molecular glue degraders has arisen as a powerful
therapeutic modality for eliminating classically undruggable disease-causing proteins …

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

JN Spradlin, X Hu, CC Ward, SM Brittain… - Nature chemical …, 2019 - nature.com
Nimbolide, a terpenoid natural product derived from the Neem tree, impairs cancer
pathogenicity; however, the direct targets and mechanisms by which nimbolide exerts its …

Click chemistry in proteomic investigations

CG Parker, MR Pratt - Cell, 2020 - cell.com
Despite advances in genetic and proteomic techniques, a complete portrait of the proteome
and its complement of dynamic interactions and modifications remains a lofty, and as of yet …

[HTML][HTML] Proteomic discovery of chemical probes that perturb protein complexes in human cells

MR Lazear, JR Remsberg, MG Jaeger, K Rothamel… - Molecular cell, 2023 - cell.com
Most human proteins lack chemical probes, and several large-scale and generalizable small-
molecule binding assays have been introduced to address this problem. How compounds …

Discovery of a covalent FEM1B recruiter for targeted protein degradation applications

NJ Henning, AG Manford, JN Spradlin… - Journal of the …, 2022 - ACS Publications
Proteolysis-targeting chimeras (PROTACs), heterobifunctional compounds that consist of
protein-targeting ligands linked to an E3 ligase recruiter, have arisen as a powerful …

Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications

CC Ward, JI Kleinman, SM Brittain, PS Lee… - ACS chemical …, 2019 - ACS Publications
Targeted protein degradation has arisen as a powerful strategy for drug discovery allowing
the targeting of undruggable proteins for proteasomal degradation. This approach most …

CysDB: a human cysteine database based on experimental quantitative chemoproteomics

LM Boatner, MF Palafox, DK Schweppe… - Cell Chemical …, 2023 - cell.com
Cysteine chemoproteomics provides proteome-wide portraits of the ligandability or potential"
druggability" for thousands of cysteine residues. Consequently, these studies are facilitating …